Diagnosing AL and ATTR amyloid cardiomyopathy

• Verfasst von: Siepen, Fabian aus dem [VerfasserIn]
• Verfasst von: Hansen, Timon [VerfasserIn]
• Titel: Diagnosing AL and ATTR amyloid cardiomyopathy
• Titelzusatz: a multidisciplinary approach
• Verf.angabe: Fabian aus dem Siepen and Timon Hansen
• E-Jahr: 2024
• Jahr: 1 October 2024
• Umfang: 12 S.
• Illustrationen: Illustrationen
• Fussnoten: Gesehen am 27.03.2025
• Weitere Titel: Titel des special issue: Advances in the Diagnosis and Treatment of Cardiomyopathy
• Titel Quelle: Enthalten in: Journal of Clinical Medicine
• Ort Quelle: Basel : MDPI, 2012
• Jahr Quelle: 2024
• Band/Heft Quelle: 13(2024), 19, special issue, Artikel-ID 5873, Seite 1-12
• ISSN Quelle: 2077-0383
• DOI: doi:10.3390/jcm13195873
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: AL
• Sach-SW: amyloidosis
• Sach-SW: ATTR
• Sach-SW: ATTR-CM
• Sach-SW: cardiomyopathy
• K10plus-PPN: 1920699740

Abstract

Amyloidosis with cardiac involvement is a fatal disease leading to progressive heart failure. The most common forms of amyloidosis with cardiac involvement are light chain (AL) and transthyretin (ATTR) amyloidosis. To allow effective specific treatment for both forms, precise and early diagnosis is important. This review focuses on diagnostic approaches for AL and ATTR amyloidosis with cardiac involvement, including different strategies, the role of imaging and biomarkers and possible pitfalls.